Global law firm White & Case LLP has advised an international bank syndicate on a €1.2 billion seven-year term loan B financing for Cheplapharm Arzneimittel GmbH (Cheplapharm).
Cheplapharm is a European leader in well-established medicines. Proceeds from the new financing will be used to partially refinance Cheplapharm's existing €1.28 billion term loan B due 2029. The refinancing follows Cheplapharm's recently announced strategic partnership with Sanofi.
The White & Case team which advised on the transaction was led by partners Vanessa Schürmann and Gernot Wagner (both Frankfurt) and included partners Andreas Lischka, Bodo Bender and Woldemar Häring (all Frankfurt), counsel Sascha H. Schmidt, David Santoro and Alexander Born (all Frankfurt), associates Marie-Christin Frowerk, Bethany Davies, Christopher Ruof, Niklas Kastenholz, Finn Pauls (all Frankfurt), Mats Cuvelier (Brussels) and Ed Pearson (London) and international attorneys Diana Machingaidze and Juliana Leao (both Frankfurt).
Press contact
For more information please speak to your local media contact.
